WHAT IS IT?
A GLP-1 (Glucagon-like peptide-1) receptor agonist.
WHAT DOES IT DO?
Delays gastric emptying, suppresses appetite via neurological pathways, and regulates insulin secretion, leading to consistent, measurable fat loss.
HOW DO I USE IT?
Subcutaneous injection once weekly. Starting dose is 0.25mg, gradually titrated up to 2.4mg weekly to mitigate gastrointestinal side effects.
DEPLOYED BY OPERATORSHEALTHTRENDS SCORE™
NO VERIFIED OPERATORS FOUND DEPLOYING THIS PROTOCOL.